TITLE

Hemodiyaliz Hastalarında HBV, HCV ve HIV Seroprevalansı ve Hepatit B Aşılaması ile Oluşan Antikor Cevabının ğerlendirilmesi

AUTHOR(S)
TEMİZ, Hakan; KAYA, Şafak; BEREKATOĞLU, Nuh; TEMİZ, Sevim; DANIŞ, Ramazan
PUB. DATE
December 2013
SOURCE
Viral Hepatitis Journal / Viral Hepatit Dergisi;Dec2013, Vol. 19 Issue 3, p140
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: In this study; we aimed to determine the the effectiveness of infection control measures in patients undergoing hemodialysis for chronic renal failure by analyzing the HBsAg, anti-HBs, anti-HCV and anti-HIV serologic indicators retrospectively. Materils and Methods: HBsAg, anti-HBs, anti-HCV and anti-HIV parameters of 96 patients receiving hemodialysis treatment in 2012 were analysed with the ADVIA Centaur XP Immunoassay System by CLIA method. Results: In this study; there was no HBsAg and anti-HIV positive patients. All the patients were regularly and fully vaccinated for hepatitis B but 10 patients (10.4%) had anti-HBs antibody level under 10 mIU/mL. 4 patients (4.1%) were positive for anti-HCV. Statistically significant difference was detected in anti-HCV positivity for hemodialysis duration, gender, history of dental treatment and the presence of hepatitis in the family. Conclusion: In conclusion; appropriate infection control measures in hemodialysis patients, immunization and education of patients and health care workers can reduce the possibility of transmission of infectious agents.
ACCESSION #
94926689

 

Related Articles

  • The duration of hepatitis B vaccine immunity in pediatric dialysis patients. Sheth, Rita; Peskin, Melissa; Du, Xianglin // Pediatric Nephrology;Oct2014, Vol. 29 Issue 10, p2029 

    Background: Dialysis patients are at risk for hepatitis B infection, a serious but preventable disease. Long-term hepatitis B protection has not been defined in pediatric patients with chronic kidney disease stage 5 on dialysis (CKD 5D) who were vaccinated as infants or children. Methods: Annual...

  • Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town. Stroffolini, T.; Guadagnino, V.; Caroleo, B.; Sarro, G.; Focà, A.; Liberto, M.; Giancotti, A.; Barreca, G.; Marascio, N.; Lombardo, F.; Staltari, O. // Infection;Jun2012, Vol. 40 Issue 3, p299 

    Purpose: Universal anti-hepatitis B vaccination of infants and of 12-year-old children became mandatory in Italy in 1991. The purpose of this study was to evaluate the persistence of anti-hepatitis B surface (HBs) antibodies several years after a primary course of vaccination. Methods: In 2010,...

  • Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy. Grosso, Giuseppe; Mistretta, Antonio; Marventano, Stefano; Ferranti, Roberta; Mauro, Luisa; Cunsolo, Rosario; Proietti, Lidia; Malaguarnera, Mariano // Hepatitis Monthly;2012, Vol. 12 Issue 9, p1 

    Background: The impact of hepatitis B virus (HBV) vaccination campaigns on HBV epidemiology needs to be evaluated, in order to assess the long-term immunity offered by vaccines against HBV. Objectives: To evaluate the current status of anti-HBV vaccine coverage among healthcare workers (HCWs) in...

  • Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong. Suen, S.; Lao, T.; Chan, O.; Lau, T.; Leung, T.; Chan, P. // Infection;Apr2013, Vol. 41 Issue 2, p529 

    Purpose: To determine the effect of age on the prevalence of hepatitis B virus (HBV) infection during a routine screening programme of first-year students enrolled in Health Sciences Studies at the Chinese University of Hong Kong from 2001 to 2009. Methods: In a retrospective cohort study, data...

  • Vascular access for chronic hemodialysis in children: arteriovenous fistula or central venous catheter? Merouani, Aicha; Lallier, Michel; Paquet, Julie; Gagnon, Johanne; Lapeyraque, Anne // Pediatric Nephrology;Dec2014, Vol. 29 Issue 12, p2395 

    Background: The choice of vascular access (VA) for hemodialysis (HD) in end-stage renal disease (ESRD) is arteriovenous fistula (AVF) or central venous catheter (CVC). Whereas clinical practice guidelines suggest AVF to preserve the vascular bed, pediatric nephrologists tend to favor CVC for...

  • Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV/AIDS Patients: A Randomized Controlled Trial. Sayad, Babak; Alavian, Seyyed Moayed; Najafi, Farid; Soltani, Bita; Shirvani, Maria; Janbakhsh, Alireza; Mansouri, Feyzollah; Afsharian, Mandana; Vaziri, Siavash; Alikhani, Arash; Bashiri, Homayoon // Hepatitis Monthly;2012, Vol. 12 Issue 9, p1 

    Background: Human immunodeficiency virus (HIV) infected patients are also frequently exposed to the hepatitis B virus (HBV), due to the common routes of transmission, therefore, prevention of hepatitis B results in decreased complications of the disease. Objectives: Since the immune response of...

  • Afyonkarahisar ve çevresinde diyalize giren kronik böbrek yetmezlikli hastalardaki deri bulguları. Güder, Semih; Karaca, Şemsettin; Kulaç, Mustafa; Yüksel, Şeref; Güder, Hüsna // Archives of the Turkish Dermatology & Venerology / Turkderm;2012, Vol. 46 Issue 4, p181 

    Background and Design: To evaluate the prevalence of skin changes in patient with chronic renal failure undergoing hemodialysis. Material and Methods: Over 18 year of age, 100 randomly selected patients were enrolled in the study. The patients were divided into 7 groups in terms of primary...

  • Effectiveness of the Targeted Hepatitis B Vaccination Program in Greenland. Børresen, Malene L.; Koch, Anders; Biggar, Robert J.; Ladefoged, Karin; Melbye, Mads; Wohlfahrt, Jan; Krause, Tyra Grove // American Journal of Public Health;Feb2012, Vol. 102 Issue 2, p277 

    Objectives. To evaluate the effectiveness of the hepatitis B virus (HBV) vaccination program in Greenland, which targets children born to mothers who are positive for HBV surface antigen (HBsAg), we determined vaccination coverage, levels of postvaccination antibodies, and frequency of...

  • Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Streja, Elani; Lau, Wei Ling; Goldstein, Leanne; Sim, John J; Molnar, Miklos Z; Nissenson, Allen R; Kovesdy, Csaba P; Kalantar-Zadeh, Kamyar // Kidney International Supplements;Dec2013, Vol. 3 Issue 5, p462 

    Elevated serum phosphorus is associated with higher death risk in hemodialysis patients. Previous studies have suggested that both higher serum parathyroid hormone (PTH) level and higher dietary protein intake may contribute to higher serum phosphorus levels. However, it is not well known how...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics